Early Success In Roche’s lidERA Adjuvant Study Builds Giredestrant’s Profile

 
• By Alexandra Shimmings
  
Cancer cells on scientific background.3d illustration
Gilead announced results of the Phase III TROPiCS-02 study of Trodelvy in HR+/HER2- metastatic breast cancer • Source: Shutterstock

More from Clinical Trials

More from R&D